1. Renton, Alan E, Chiò, Adriano, Traynor, Bryan J. 2013. State of play in amyotrophic lateral sclerosis genetics. In Nature neuroscience, 17, 17-23. doi:10.1038/nn.3584. https://pubmed.ncbi.nlm.nih.gov/24369373/
2. Kim, Sang Hwa, Nichols, Kye D, Anderson, Eric N, Pandey, Udai Bhan, Tibbetts, Randal S. 2023. Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2. In eLife, 12, . doi:10.7554/eLife.84382. https://pubmed.ncbi.nlm.nih.gov/37039476/
3. Renaud, Laurence, Picher-Martel, Vincent, Codron, Philippe, Julien, Jean-Pierre. 2019. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. In Acta neuropathologica communications, 7, 103. doi:10.1186/s40478-019-0758-7. https://pubmed.ncbi.nlm.nih.gov/31319884/
4. Ling, Shuo-Chien, Polymenidou, Magdalini, Cleveland, Don W. . Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. In Neuron, 79, 416-38. doi:10.1016/j.neuron.2013.07.033. https://pubmed.ncbi.nlm.nih.gov/23931993/
5. Black, Holly H, Hanson, Jessica L, Roberts, Julia E, Lau, Cristina I, Whiteley, Alexandra M. 2023. UBQLN2 restrains the domesticated retrotransposon PEG10 to maintain neuronal health in ALS. In eLife, 12, . doi:10.7554/eLife.79452. https://pubmed.ncbi.nlm.nih.gov/36951542/